Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Congenica Closes $50M Series C Funding Round

Congenica Closes $50M Series C Funding Round

Nov 09, 2020
|
staff reporter

NEW YORK – Congenica said Monday that it has closed a $50 million Series C round of venture capital.

Tencent and Legal & General co-led the round, with participation from new investors Xeraya, Puhua Capital, and IDO Investments. Previous Congenica investors Parkwalk, Cambridge Innovation Capital, and Downing also contributed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Germany to Increase Viral Sequencing

Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.

Getting Used to It

23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.

Green Access at Science

The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.

Science Papers Examine Chronic Kidney Disease GWAS, Pneumonia Microbiome

In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.

What's Popular?

In Business News

  1. Bionano Genomics Stock Soars on User Presentations, Public Stock Offering, Renewed Nasdaq Compliance

  2. Ancestry to Discontinue NGS-Based AncestryHealth Service

  3. Pacific Biosciences CEO Discusses Q4 Results, New Sequencing Platforms at JP Morgan

  4. People in the News: Broad Institute's Eric Lander Named White House Science Advisor; More

  5. JP Morgan Healthcare Conference 2021, Day 3: Exact Sciences, Danaher, NanoString, Bio-Techne, More

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.